Cargando…

Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer

Background. To explore preferred and actual involvement in chemotherapy decision making among stage II and III colon cancer (CC) patients by sociodemographic, interpersonal, and intrapersonal communication factors. Methods. Cross-sectional exploratory study collecting self-reported survey data from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Austin, Jessica D., Shelton, Elizabeth, Crookes, Danielle M., Tehranifar, Parisa, Neugut, Alfred I., Shelton, Rachel C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052499/ https://www.ncbi.nlm.nih.gov/pubmed/37009635 http://dx.doi.org/10.1177/23814683231163189

Ejemplares similares

Erratum to “Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer”
Publicado: (2023)

Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa
por: Tan, Sarah Xinhui, et al.
Publicado: (2023)

Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals
por: Pumpalova, Yoanna, et al.
Publicado: (2021)

“It's something I'll do until I die”: A qualitative examination into why older women in the U.S. continue screening mammography
por: Brotzman, Laura E., et al.
Publicado: (2022)

A mixed-methods study of multi-level factors influencing mammography overuse among an older ethnically diverse screening population: implications for de-implementation
por: Austin, Jessica D., et al.
Publicado: (2021)

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2015)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer—A Clinical Vignette Study
por: To, Yat Hang, et al.
Publicado: (2023)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer
por: Batra, Atul, et al.
Publicado: (2020)

Breast Density Awareness and Knowledge in a Mammography Screening Cohort of Predominantly Hispanic Women: Does Breast Density Notification Matter?
por: Austin, Jessica D., et al.
Publicado: (2021)

Adjuvant Chemotherapy for Stage II Colon Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2020)

Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
por: Hu, Huabin, et al.
Publicado: (2020)

Survival and time interval from surgery to the start of chemotherapy for patients with stage II and III colon cancer
por: Ganenko, Denis, et al.
Publicado: (2018)

Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review
por: To, Yat Hang, et al.
Publicado: (2023)

Association of collagen deep learning classifier with prognosis and chemotherapy benefits in stage II‐III colon cancer
por: Jiang, Wei, et al.
Publicado: (2023)

Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making
por: Shelton, Charles, et al.
Publicado: (2023)

Decision-Making about the HPV Vaccine among Ethnically Diverse Parents: Implications for Health Communications
por: Allen, Jennifer D., et al.
Publicado: (2012)

High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

De-escalating chemotherapy for stage II colon cancer?
por: Fu, Jianfei, et al.
Publicado: (2019)

Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer
por: Sebio, Ana, et al.
Publicado: (2015)

The Predictive and Guidance Value of Signet Ring Cell Histology for Stage II/III Colon Cancer Response to Chemotherapy
por: Jiang, Huici, et al.
Publicado: (2021)

Predictors of activity level and retention among African American lay health advisors (LHAs) from The National Witness Project: Implications for the implementation and sustainability of community-based LHA programs from a longitudinal study
por: Shelton, Rachel C., et al.
Publicado: (2016)

Making the connection between health equity and sustainability
por: Shelton, Rachel C., et al.
Publicado: (2023)

The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients
por: Xu, Fang, et al.
Publicado: (2014)

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)

Geriatric functional assessment for decision-making on adjuvant chemotherapy in older colon cancer patients
por: Bang, Hyun Jin, et al.
Publicado: (2022)

The Role of Tumor Deposits in Predicting the Efficacy of Chemotherapy in Stage III Colon Cancer
por: Shi, Mingyu, et al.
Publicado: (2020)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer
por: Shanmugam, Chandrakumar, et al.
Publicado: (2011)

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I‐II or unresected stage III pancreatic cancer
por: Ma, Sung J., et al.
Publicado: (2019)

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
por: Schippinger, W, et al.
Publicado: (2007)

Breast cancer worry, uncertainty, and perceived risk following breast density notification in a longitudinal mammography screening cohort
por: Lee Argov, Erica J., et al.
Publicado: (2022)

Adjuvant chemotherapy for stage II colon cancer: who really needs it
por: Yang, Yan, et al.
Publicado: (2018)

The Survival Effect of Radiotherapy on Stage II/III Rectal Cancer in Different Age Groups: Formulating Radiotherapy Decision-Making Based on Age
por: Li, Yuqiang, et al.
Publicado: (2021)

Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer
por: Jeong, Woon Kyung, et al.
Publicado: (2015)

Shortening adjuvant chemotherapy in stage III colon cancer: are we ready for a change?
por: Roda, Desamparados, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o4nf4hguq397ke2hum7dio95kk